Tablet

Description

FIG. 1 is a top plan view of a tablet showing our new design;

FIG. 2 is a front elevational view thereof;

FIG. 3 is a right side elevational view thereof, the left side elevational view being the same in appearance;

FIG. 4 is a bottom plan view thereof;

FIG. 5 is a sectioned right side elevation view thereof, taken along section line 5--5 of FIG. 1;

FIG. 6 is a sectioned front elevation view thereof, taken along section line 6--6 of FIG. 3; and,

FIG. 7 is a rear elevational view thereof.

Referenced Cited
U.S. Patent Documents
D31133 July 1899 Lantz
D213873 April 1969 Bryan
237861 February 1881 Hare
D255727 July 1, 1980 Grodin
D258091 January 27, 1981 Reed et al.
D285490 September 2, 1986 Tovey
D301764 June 20, 1989 Contractor et al.
D302051 July 4, 1989 Contractor et al.
D304626 November 14, 1989 Contractor et al.
462990 November 1891 Oppenheimer
2584166 February 1952 Stevenson et al.
Other references
  • Drug Standards tablet and capsule shapes, p. 126, Sep.-Oct. 1959. Physicians' Desk Reference, Zorprin.RTM. p. 406, Vicodin ES.RTM. p. 413, Theolair.TM. regular-release tablets p. 416, Demem.RTM. hydrochloride tablets p. 435, 44th ed, 1990. Physicians' Desk Reference, Phenergan.RTM., p. 439, 34th ed., 1980.
Patent History
Patent number: D359554
Type: Grant
Filed: Feb 23, 1994
Date of Patent: Jun 20, 1995
Assignee: The Procter & Gamble Company (Cincinnati, OH)
Inventors: Richard J. Dansereau (Sherburne, NY), Christopher R. Calhoun (Norwich, NY)
Primary Examiner: Melanie H. Tung
Attorneys: Ronald W. Kock, Kevin C. Johnson, Eileen L. Hughett
Application Number: 0/26,882
Classifications
Current U.S. Class: Tablet Or Caplet (1) (D24/101)